Dr. Parvaneh Bahmani, MD

Dr. Bahmani practices at U.S. Renal Care Culver City in Culver City, California.

Dr. Bahmani's NPI, 1609887678, was assigned on August 11, 2006. Dr. Bahmani graduated from Shahid Beheshti University of Medical Sciences in 1995. Dr. Bahmani holds California license A81644.

Dr. Bahmani's primary practice is U.S. Renal Care Culver City, at 9808 Venice Boulevard, Suite #200, Culver City, CA 90232 in Los Angeles County. The practice phone is (323) 692-0700.

Dr. Bahmani's primary practice is U.S. Renal Care Culver City in Culver City, California. Dr. Bahmani is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Parvaneh Bahmani, MD. Dmand AI also links Dr. Bahmani to 3 more hospitals, 3 home health agencies, 1 dialysis center, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bahmani practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bahmani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bahmani is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Bahmani treats.

CMS data shows 8,634 Medicare services from Dr. Bahmani across 16 procedure codes in 2024, for 976 Medicare patients. Medicare paid $968,791 for them.

CMS counts 976 Medicare patients who saw Dr. Bahmani in 2024. The largest group is 65 to 74, with 380 patients. 75% of them have arthritis, and 75% have chronic kidney disease. 82% are also on Medicaid. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bahmani's median patient age at 63, with 49% women.

In 2024, Dr. Bahmani wrote 6,992 Medicare Part D claims for 283 patients. 72% of them were for generic drugs. CMS names the drug for 6,261 of them, across 148 drugs with 11 or more claims each, at $6,280,117 in total drug cost. In 2023, CMS named 5,833 claims across 147 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Bahmani for performance year 2024, reported individually. Dr. Bahmani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bahmani as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 544 general payments to Dr. Bahmani from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. ViiV Healthcare Company paid the most, $3,222.

Dr. Bahmani graduated from Shahid Beheshti University of Medical Sciences in 1995.

Dr. Bahmani is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.